Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anterix Inc.ATEX · Entity 4597 | Director · Executive Chairman | May 20, 2026 | August 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anterix Inc.
Report date May 20, 2026 · Filed August 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,731 |
Ending reported balance
After 2026-08-24 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2026-05-20 · Grant · Acquired 2,791 · Balance 19,385 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock. The RSU vests in full on the earlier of: (i) May 20, 2027, and (ii) the Issuer's next annual stockholder meeting. Row 2 · 2026-06-18 · Sale · Disposed 1,654 · Balance 17,731 F2: These shares of Common Stock were automatically sold in a non-discretionary transaction to cover tax withholding obligations upon the settlement of certain time-based RSU awards. Row 3 · 2026-08-24 · Exercise / conversion · Acquired 10,000 · Balance 27,731 Row 4 · 2026-08-24 · Sale · Disposed 4,392 · Balance 23,339 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.67 to $88.66, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Row 5 · 2026-08-24 · Sale · Disposed 4,418 · Balance 18,921 F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.71 to $89.67, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Row 6 · 2026-08-24 · Sale · Disposed 790 · Balance 18,131 F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.79 to $90.51, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Row 7 · 2026-08-24 · Sale · Disposed 400 · Balance 17,731 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.62 · Expires 2034-01-02 | Direct | 48,998 |
Reported balance
After 2026-08-24 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-24 · Exercise / conversion · Disposed 10,000 · Balance 48,998 F6: 1/3rd of the option shares vest and become exercisable on January 2, 2025, with the remaining option shares vesting in two equal annual installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock. The RSU vests in full on the earlier of: (i) May 20, 2027, and (ii) the Issuer's next annual stockholder meeting.
F2: These shares of Common Stock were automatically sold in a non-discretionary transaction to cover tax withholding obligations upon the settlement of certain time-based RSU awards.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.67 to $88.66, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.71 to $89.67, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.79 to $90.51, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F6: 1/3rd of the option shares vest and become exercisable on January 2, 2025, with the remaining option shares vesting in two equal annual installments thereafter.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Itron Networked Solutions, Inc.
Report date January 05, 2018 · Filed January 09, 2018
Section 16 reporting ended · disclosed 2018-01-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-01-05 transaction · row 1
1 source rowRow 1 · 2018-01-05 · Disposition to issuer · Disposed 94,401 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger dated September 17, 2017 by and among the Issuer, Itron, Inc. ("Itron") and Ivory Merger Sub., Inc., a wholly-owned subsidiary of Itron (the "Merger Agreement"), in exchange for the right to receive cash in the amount of $16.25 per share (the "Merger Consideration"). |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.60 · Expires 2018-12-22 | Direct | 0 |
Reported balance
After 2018-01-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-01-05 · Disposition to issuer · Disposed 5,000 · Balance 0 F2: This option, which is fully vested, was canceled pursuant to the Merger Agreement in exchange for the right to receive cash in the amount of $12.65 per share, representing the difference between the per share exercise price of this option and the Merger Consideration. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.00 · Expires 2021-04-21 | Direct | 0 |
Reported balance
After 2018-01-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-01-05 · Disposition to issuer · Disposed 5,000 · Balance 0 F3: This option, which is fully vested, was canceled pursuant to the Merger Agreement. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.00 · Expires 2021-05-19 | Direct | 0 |
Reported balance
After 2018-01-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-01-05 · Disposition to issuer · Disposed 5,000 · Balance 0 F3: This option, which is fully vested, was canceled pursuant to the Merger Agreement. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.00 · Expires 2023-03-11 | Direct | 0 |
Reported balance
After 2018-01-05 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-01-05 · Disposition to issuer · Disposed 5,000 · Balance 0 F3: This option, which is fully vested, was canceled pursuant to the Merger Agreement. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.48 · Expires 2023-05-22 | Direct | 0 |
Reported balance
After 2018-01-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-01-05 · Disposition to issuer · Disposed 16,038 · Balance 0 F3: This option, which is fully vested, was canceled pursuant to the Merger Agreement. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-01-05 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-01-05 · Disposition to issuer · Disposed 19,467 · Balance 0 F4: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, these RSUs became fully vested and were immediately settled and converted into the right to receive cash equal to the amount of the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger dated September 17, 2017 by and among the Issuer, Itron, Inc. ("Itron") and Ivory Merger Sub., Inc., a wholly-owned subsidiary of Itron (the "Merger Agreement"), in exchange for the right to receive cash in the amount of $16.25 per share (the "Merger Consideration").
F2: This option, which is fully vested, was canceled pursuant to the Merger Agreement in exchange for the right to receive cash in the amount of $12.65 per share, representing the difference between the per share exercise price of this option and the Merger Consideration.
F3: This option, which is fully vested, was canceled pursuant to the Merger Agreement.
F4: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F5: Pursuant to the Merger Agreement, these RSUs became fully vested and were immediately settled and converted into the right to receive cash equal to the amount of the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 24, 2026 Filed Aug 26, 2026 20:46 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $33.62 | $0.00 |
DisclosureSEC source: 0001571521-26-000002 · wk-form4_1787777198.xml · derivative · entry 8 Kuhn Thomas R. · CIK 0001571521 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,998 Underlying: Common Stock · 10,000 shares Expires 2034-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 1/3rd of the option shares vest and become exercisable on January 2, 2025, with the remaining option shares vesting in two equal annual installments thereafter. Read SEC document |
| August 24, 2026 Filed Aug 26, 2026 20:46 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 400 | $91.01 | $36,404.00 |
DisclosureSEC source: 0001571521-26-000002 · wk-form4_1787777198.xml · nonDerivative · entry 7 Kuhn Thomas R. · CIK 0001571521 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,731 Read SEC document |
| August 24, 2026 Filed Aug 26, 2026 20:46 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 790 | $90.00 | $71,100.71 |
DisclosureSEC source: 0001571521-26-000002 · wk-form4_1787777198.xml · nonDerivative · entry 6 Kuhn Thomas R. · CIK 0001571521 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,131 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.79 to $90.51, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 24, 2026 Filed Aug 26, 2026 20:46 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 4,418 | $89.12 | $393,726.42 |
DisclosureSEC source: 0001571521-26-000002 · wk-form4_1787777198.xml · nonDerivative · entry 5 Kuhn Thomas R. · CIK 0001571521 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,921 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.71 to $89.67, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 24, 2026 Filed Aug 26, 2026 20:46 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 4,392 | $88.18 | $387,295.34 |
DisclosureSEC source: 0001571521-26-000002 · wk-form4_1787777198.xml · nonDerivative · entry 4 Kuhn Thomas R. · CIK 0001571521 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,339 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.67 to $88.66, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 24, 2026 Filed Aug 26, 2026 20:46 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 10,000 | $33.62 | $336,200.00 |
DisclosureSEC source: 0001571521-26-000002 · wk-form4_1787777198.xml · nonDerivative · entry 3 Kuhn Thomas R. · CIK 0001571521 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2026 Filed Aug 26, 2026 20:46 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 1,654 | $79.52 | $131,526.08 |
DisclosureSEC source: 0001571521-26-000002 · wk-form4_1787777198.xml · nonDerivative · entry 2 Kuhn Thomas R. · CIK 0001571521 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,731 F2 · kind: These shares of Common Stock were automatically sold in a non-discretionary transaction to cover tax withholding obligations upon the settlement of certain time-based RSU awards. Read SEC document |
| May 20, 2026 Filed Aug 26, 2026 20:46 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 2,791 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001571521-26-000002 · wk-form4_1787777198.xml · nonDerivative · entry 1 Kuhn Thomas R. · CIK 0001571521 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,385 F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock. The RSU vests in full on the earlier of: (i) May 20, 2027, and (ii) the Issuer's next annual stockholder meeting. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 22:28 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 6,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001304492-25-000050 · wk-form4_1750112874.xml · nonDerivative · entry 1 Kuhn Thomas R. · CIK 0001571521 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,594 F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock. The RSU vests in full on the earlier of: (i) June 12, 2026, and (ii) the Issuer's next annual stockholder meeting. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 22:24 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 56,803 | $0.00 Strike: $29.84 | $0.00 |
DisclosureSEC source: 0001304492-25-000018 · wk-form4_1737757484.xml · derivative · entry 1 Kuhn Thomas R. · CIK 0001571521 · Director · Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,803 Underlying: Common Stock · 56,803 shares Expires 2035-01-22 F1 · derivative.exercise_date: The option shares shall vest in full and become exercisable on January 22, 2028, subject to the Reporting Person's continued service with the Issuer through this date. Read SEC document |
| December 26, 2024 Filed Dec 30, 2024 22:08 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 61,804 | $0.00 Strike: $31.25 | $0.00 |
DisclosureSEC source: 0001304492-24-000147 · wk-form4_1735596483.xml · derivative · entry 1 Kuhn Thomas R. · CIK 0001571521 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,804 Underlying: Common Stock · 61,804 shares Expires 2034-12-26 F1 · derivative.exercise_date: The option shares vest in full on December 26, 2027, subject to the Reporting Person's continued service with the Issuer through this date. Read SEC document |
| December 26, 2024 Filed Jan 14, 2025 21:16 UTC Amendment | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 7,108 | $0.00 Strike: $31.25 | $0.00 |
DisclosureSEC source: 0001304492-25-000006 · wk-form4a_1736889361.xml · derivative · entry 1 Kuhn Thomas R. · CIK 0001571521 · Director · Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,108 Underlying: Common Stock · 7,108 shares Expires 2034-12-26 F1 · shares: This amended Form 4 is being filed to correct the previously reported grant amount of 61,804 option shares to the Reporting Person to reflect an actual grant of 7,108 option shares. The previously reported amount exceeded the compensation limit for non-employee directors set forth in the Issuer's 2023 Stock Plan by 54,696 option shares (the "Excess Option Shares"). The grant of the Excess Option Shares was null and void and has been rescinded by the Issuer. F2 · derivative.exercise_date: The option shares vest in full on December 26, 2027, subject to the Reporting Person's continued service with the Issuer through this date. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 23:59 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 6,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001304492-24-000134 · wk-form4_1733788741.xml · nonDerivative · entry 1 Kuhn Thomas R. · CIK 0001571521 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,472 F1 · shares: The restricted stock vests in full on the earlier of (i) December 5, 2025 or (ii) the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| December 05, 2024 Filed Dec 18, 2024 00:27 UTC Amendment | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 6,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001304492-24-000142 · wk-form4a_1734481617.xml · nonDerivative · entry 1 Kuhn Thomas R. · CIK 0001571521 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,372 F1 · shares: The prior Form 4 incorrectly reported the restricted stock grant for 6,574 shares. F2 · shares: The restricted stock vests in full on the earlier of (i) December 5, 2025 or (ii) the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:52 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 58,998 | $0.00 Strike: $33.62 | $0.00 |
DisclosureSEC source: 0001304492-24-000012 · wk-form4_1704408742.xml · derivative · entry 2 Kuhn Thomas R. · CIK 0001571521 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,998 Underlying: Common Stock · 58,998 shares Expires 2034-01-02 F2 · security: Options awarded in connection with director's appointment to the Board as Vice Chairman. For further information see the Anterix Inc. Form 8-K filed with the Securities Exchange Commission on January 4, 2024. F3 · derivative.exercise_date: 1/3rd of the option shares vest and become exercisable on January 2, 2025, with the remaining option shares vesting in 2 equal annual installments thereafter. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:52 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 3,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001304492-24-000012 · wk-form4_1704408742.xml · nonDerivative · entry 1 Kuhn Thomas R. · CIK 0001571521 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,898 F1 · shares: The restricted stock vests in full on August 7, 2024. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 20:48 UTC | Itron Networked Solutions, Inc. SSNI · Entity 170408 | Disposition to issuerRestricted Stock Units · Derivative | 19,467 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-001514 · doc1.xml · derivative · entry 7 Kuhn Thomas R. · CIK 0001571521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,467 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, these RSUs became fully vested and were immediately settled and converted into the right to receive cash equal to the amount of the Merger Consideration. F5 · derivative.expiration_date: Pursuant to the Merger Agreement, these RSUs became fully vested and were immediately settled and converted into the right to receive cash equal to the amount of the Merger Consideration. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 20:48 UTC | Itron Networked Solutions, Inc. SSNI · Entity 170408 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 16,038 | $0.00 Strike: $19.48 | $0.00 |
DisclosureSEC source: 0001140361-18-001514 · doc1.xml · derivative · entry 6 Kuhn Thomas R. · CIK 0001571521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,038 shares Expires 2023-05-22 F3 · derivative.exercise_date: This option, which is fully vested, was canceled pursuant to the Merger Agreement. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 20:48 UTC | Itron Networked Solutions, Inc. SSNI · Entity 170408 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001140361-18-001514 · doc1.xml · derivative · entry 5 Kuhn Thomas R. · CIK 0001571521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2023-03-11 F3 · derivative.exercise_date: This option, which is fully vested, was canceled pursuant to the Merger Agreement. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 20:48 UTC | Itron Networked Solutions, Inc. SSNI · Entity 170408 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001140361-18-001514 · doc1.xml · derivative · entry 4 Kuhn Thomas R. · CIK 0001571521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-05-19 F3 · derivative.exercise_date: This option, which is fully vested, was canceled pursuant to the Merger Agreement. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 20:48 UTC | Itron Networked Solutions, Inc. SSNI · Entity 170408 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001140361-18-001514 · doc1.xml · derivative · entry 3 Kuhn Thomas R. · CIK 0001571521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-04-21 F3 · derivative.exercise_date: This option, which is fully vested, was canceled pursuant to the Merger Agreement. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 20:48 UTC | Itron Networked Solutions, Inc. SSNI · Entity 170408 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001140361-18-001514 · doc1.xml · derivative · entry 2 Kuhn Thomas R. · CIK 0001571521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2018-12-22 F2 · derivative.exercise_date: This option, which is fully vested, was canceled pursuant to the Merger Agreement in exchange for the right to receive cash in the amount of $12.65 per share, representing the difference between the per share exercise price of this option and the Merger Consideration. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 20:48 UTC | Itron Networked Solutions, Inc. SSNI · Entity 170408 | Disposition to issuerCommon Stock | 94,401 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-001514 · doc1.xml · nonDerivative · entry 1 Kuhn Thomas R. · CIK 0001571521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to the Agreement and Plan of Merger dated September 17, 2017 by and among the Issuer, Itron, Inc. ("Itron") and Ivory Merger Sub., Inc., a wholly-owned subsidiary of Itron (the "Merger Agreement"), in exchange for the right to receive cash in the amount of $16.25 per share (the "Merger Consideration"). Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 18:08 UTC | Itron Networked Solutions, Inc. SSNI · Entity 170408 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001140361-17-034458 · doc1.xml · derivative · entry 3 Kuhn Thomas R. · CIK 0001571521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option grant is 100% vested and immediately exercisable. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 18:08 UTC | Itron Networked Solutions, Inc. SSNI · Entity 170408 | Exercise / conversionCommon Stock | 10,000 | $1.10 | $11,000.00 |
DisclosureSEC source: 0001140361-17-034458 · doc1.xml · nonDerivative · entry 2 Kuhn Thomas R. · CIK 0001571521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2017 Filed Sep 6, 2017 18:08 UTC | Itron Networked Solutions, Inc. SSNI · Entity 170408 | GiftCommon Stock | 653 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-034458 · doc1.xml · nonDerivative · entry 1 Kuhn Thomas R. · CIK 0001571521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,401 Read SEC document |
| May 25, 2017 Filed May 30, 2017 19:43 UTC | Itron Networked Solutions, Inc. SSNI · Entity 170408 | GrantRestricted Stock Units · Derivative | 19,467 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022936 · doc1.xml · derivative · entry 3 Kuhn Thomas R. · CIK 0001571521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,467 Underlying: Common Stock · 19,467 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: The RSUs vest as to 100% of the shares at the earlier date of: (i) the Issuer's 2018 Annual Meeting of Stockholders or (ii) May 25, 2018. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. F4 · derivative.expiration_date: The RSUs vest as to 100% of the shares at the earlier date of: (i) the Issuer's 2018 Annual Meeting of Stockholders or (ii) May 25, 2018. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. Read SEC document |
| May 25, 2017 Filed May 30, 2017 19:43 UTC | Itron Networked Solutions, Inc. SSNI · Entity 170408 | Exercise / conversionRestricted Stock Units · Derivative | 15,787 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022936 · doc1.xml · derivative · entry 2 Kuhn Thomas R. · CIK 0001571521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,787 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on June 2, 2016. F3 · derivative.exercise_date: The RSUs vest as to 100% of the shares at the earlier date of: (i) the Issuer's 2017 Annual Meeting of Stockholders or (ii) June 2, 2017. F3 · derivative.expiration_date: The RSUs vest as to 100% of the shares at the earlier date of: (i) the Issuer's 2017 Annual Meeting of Stockholders or (ii) June 2, 2017. Read SEC document |
| May 25, 2017 Filed May 30, 2017 19:43 UTC | Itron Networked Solutions, Inc. SSNI · Entity 170408 | Exercise / conversionCommon Stock | 15,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022936 · doc1.xml · nonDerivative · entry 1 Kuhn Thomas R. · CIK 0001571521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on June 2, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.